|
Sitagliptin Phosphate Monohydrate
A DPP4 inhibitor
Product Overview
Product Name: Sitagliptin Phosphate Monohydrate
Alternate Name/Synonyms: 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate; MK-0431
Description: An anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release , stimulates the insulin release and lowers blood glucose.
Peptide Sequence: N/A
Appearance: White solid
Formulation: N/A
CAS Number: 654671-77-9
Molecular Formula: C₁₆H₁₅F₆N₅O•H₃PO₄•H₂O
Molecular Weight: 523.32
Purity: ≥98% by HPLC
Solubility:H₂O
Storage Temp.: -20°C
Shipping Conditions: gel pack
Handling: Protect from air and moisture
SMILES: C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O
InChi: InChI=1S/C16H15F6N5O.H3O4P.H2O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-5(2,3)4;/h4,6,9H,1-3,5,7,23H2;(H3,1,2,3,4);1H2/t9-;;/m1../s1
InChi Key: GQPYTJVDPQTBQC-KLQYNRQASA-N
PubChem CID: 11591741
MDL Number: MFCD10001393
USAGE: For Research Use Only! Not For Use in Humans. |